J & J’s COVID-19 vaccine booster was 85% effective against hospitalization in a South African study

Date:

Johnson & Johnson
JNJ,
+ 1.11%

A Phase 3 study in South Africa showed that booster vaccination with the COVID-19 vaccine was 85% effective in preventing COVID-19-related hospitalizations, he said Thursday. The pharmaceutical company said the study conducted by the South African Medical Research Council was conducted from mid-November to mid-December. This was after Omicron became the major variant. Matthew Mamen, J & J’s Global Head of Janssen, said: Research and Development LLC.J & J’s share price, which remained largely unchanged in pre-market trading, rose 9.0% this year, but the Dow Jones Industrial Average averaged 30 stocks.
DJIA,
+ 0.25%

It is 19.2% ahead.

J & J’s COVID-19 vaccine booster was 85% effective against hospitalization in a South African study

Source link J & J’s COVID-19 vaccine booster was 85% effective against hospitalization in a South African study

The post J & J’s COVID-19 vaccine booster was 85% effective against hospitalization in a South African study appeared first on Eminetra.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Popular

More like this
Related

Uniswap: Why Ethereum whales are not the agents needed for a ‘twist of fate’

Uniswap broke into the top cryptocurrencies held by...

Sick Psycho Protesters Scream at Ashli Babbitt Mother at Solidarity Rally (VIDEO)

The left is sick. Earlier today, patriots gathered in Washington,...

DOGE and SHIB Price Analysis for September 24

Disclaimer: The opinion expressed here is not investment advice...